MSF letter to ViiV asking the company to withdraw problematic purchasing conditions for HIV prevention drug CAB-LA

CAB-LA is a game-changing HIV prevention medicine, but access to it is currently a challenge.

Thousands of deaths from a fungal infection of the brain called cryptococcal meningitis (CM) could potentially be averted every year in South Africa if an antifungal medicine called flucytosine is widely available.

It is unacceptable that people living with HIV are still dying because the tests, treatment and care for life-threatening infections are not available.

Regarding the text of the declaration for the upcoming UN High-Level Meeting (HLM) on HIV/AIDS, MSF released this statement urging all countries to recognise and retain the full rights and use of international public health safeguards ...

Eswatini has the highest percentage of people living with HIV in the world. Almost one-thirds of adults are HIV-positive. The country is also severely affected by a tuberculosis (TB) epidemic and around 70% of all TB patients are co ...

Present in the country since 2007, MSF has adapted the way it treats people with HIV and TB in times of COVID-19. In this video, Michelle Daka, MSF Nurse Activity Manager, explains the innovative and creative approaches MSF teams are ...